Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Rigel Pharmaceuticals, Inc. (RIGL) -- Ignore unavailable to you. Want to Upgrade?

To: keokalani'nui who wrote (40)	3/9/2002 2:52:56 PM
From: Mike McFarland	Read Replies (1) \| Respond to of 566

Yes, Rigel will have to collect safety data during the clinical development of their drugs <g>. (heheh...I had to google for it. And for the many nonbiotechies...ADMET is absorption, distribution, metabolism, excretion, and toxicity--and apparently this is also part of the target validation process too) So...this is something folks may want to print for the Rigel file, and it is where I found the answer to today's quiz. iscpubs.com